In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Aclaris Therapeutics Inc (NASDAQ: ACRS) closed at $1.26 in the last session, down -3.82% from day before closing price of $1.31. In other words, the price has decreased by -$3.82 from its previous closing price. On the day, 0.52 million shares were traded.
Ratios:
We take a closer look at ACRS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.06 and its Current Ratio is at 5.06. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 23, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.67 while its Price-to-Book (P/B) ratio in mrq is 0.95.
Stock Price History:
Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -13.45%, while the 200-Day Moving Average is calculated to be -33.88%.
Shares Statistics:
A total of 108.27M shares are outstanding, with a floating share count of 91.66M. Insiders hold about 15.35% of the company’s shares, while institutions hold 72.48% stake in the company.
